[HTML][HTML] The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges
JA Malik, S Ahmed, A Mir, M Shinde, O Bender… - Journal of infection and …, 2022 - Elsevier
Abstract Background The SARS-CoV-2 coronavirus epidemic is hastening the discovery of
the most efficient vaccines. The development of cost-effective vaccines seems to be the only …
the most efficient vaccines. The development of cost-effective vaccines seems to be the only …
[HTML][HTML] The impact of the COVID-19 pandemic on social, health, and economy
VJ Clemente-Suárez, E Navarro-Jiménez… - Sustainability, 2021 - mdpi.com
In late December 2019, a series of acute atypical respiratory disease occurred in Wuhan,
China, which rapidly spread to other areas worldwide. It was soon discovered that a novel …
China, which rapidly spread to other areas worldwide. It was soon discovered that a novel …
[HTML][HTML] Vaccine hesitancy: the next challenge in the fight against COVID-19
Vaccine hesitancy remains a barrier to full population inoculation against highly infectious
diseases. Coincident with the rapid developments of COVID-19 vaccines globally, concerns …
diseases. Coincident with the rapid developments of COVID-19 vaccines globally, concerns …
[HTML][HTML] Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older …
Summary Background In January, 2021, a vaccination campaign against COVID-19 was
initiated with the rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines in Argentina …
initiated with the rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines in Argentina …
[HTML][HTML] Increased COVID-19 vaccination hesitancy and health awareness amid COVID-19 vaccinations programs in Israel
M Shacham, L Greenblatt-Kimron… - International journal of …, 2021 - mdpi.com
In January 2021, Israel started vaccinating healthcare workers (HCWs) and individuals older
than 65 years with COVID-19 vaccines. Scientific literature points to vaccine hesitancy as …
than 65 years with COVID-19 vaccines. Scientific literature points to vaccine hesitancy as …
[HTML][HTML] COVID-19 vaccine hesitancy and willingness to pay: Emergent factors from a cross-sectional study in Nigeria
OP Adigwe - Vaccine: X, 2021 - Elsevier
Introduction Prior to the COVID-19 pandemic, it took at least several years to develop
vaccines for prevention of infectious diseases. The COVID-19 vaccine is the first to be …
vaccines for prevention of infectious diseases. The COVID-19 vaccine is the first to be …
Creating a framework for conducting randomized clinical trials during disease outbreaks
NE Dean, PS Gsell, R Brookmeyer… - … England Journal of …, 2020 - Mass Medical Soc
Responding to Global Infectious Disease Outbreaks As in the ongoing Covid-19 pandemic,
global outbreaks of infectious illnesses often develop quickly and resolve in unpredictable …
global outbreaks of infectious illnesses often develop quickly and resolve in unpredictable …
[HTML][HTML] Livestock disease resilience: from individual to herd level
Infectious diseases are a major threat to the sustainable production of high-producing
animals. Control efforts, such as vaccination or breeding approaches often target …
animals. Control efforts, such as vaccination or breeding approaches often target …
[HTML][HTML] Two centuries of vaccination: historical and conceptual approach and future perspectives
Over the past two centuries, vaccines have been critical for the prevention of infectious
diseases and are considered milestones in the medical and public health history. The World …
diseases and are considered milestones in the medical and public health history. The World …
Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials
To rapidly evaluate the safety and efficacy of COVID-19 vaccine candidates, prioritizing
vaccine trial sites in areas with high expected disease incidence can speed endpoint …
vaccine trial sites in areas with high expected disease incidence can speed endpoint …